Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PAFAH1B2P2 is a pseudogene related to the PAFAH1B2 locus, which encodes the beta subunit of platelet-activating factor acetylhydrolase 1b, a cytosolic enzyme involved in hydrolase activity of platelet-activating factor and related lipid mediators[1][2][3][4]. Pseudogenes like PAFAH1B2P2 are typically non-functional segments of DNA that arose from duplication or retrotransposition events; they do not encode active proteins and are not considered drug targets[3][4]. The functional protein, PAFAH1B2, has roles in lipid metabolism, cancer progression, drug (aspirin) metabolism, and neurodevelopment, but PAFAH1B2P2 itself does not have reported biological activity or therapeutic relevance[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PAFAH1B2 pseudogene 2 (PAFAH1B2P2).